| Literature DB >> 23821693 |
Daniel D'Agostino1, Alejandro Costaguta, Fernando Álvarez.
Abstract
Autoimmune hepatitis is a severe liver disease in which ~10% of patients do not respond to standard treatment. We describe a new rescue therapy using anti-CD20 monoclonal antibodies (rituximab). Complete remission was obtained and maintained by using low doses of immunosuppressive drugs with repeated anti-CD20 infusions.Entities:
Keywords: autoimmune hepatitis; children; rituximab; treatment
Mesh：
Substances：
Year: 2013 PMID： 23821693 DOI： 10.1542/peds.2011-1900
Source DB: PubMed Journal: Pediatrics ISSN： 0031-4005 Impact factor: 7.124